Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Trump and Xi agree to trade truce, with plans for reciprocal measures and follow-up visits, but details remain unclear as Trump orders nuclear testing.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Trump and Xi agree to trade truce, with plans for reciprocal measures and follow-up visits, but details remain unclear as Trump orders nuclear testing.